From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast : an absolute shocker from the FCA - Zamaz & free Cineworld cash thanks to the morons

By Tom Winnifrith | Friday 2 September 2022


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I end with some logistics on Sharestock, booking for supper, tickets etc - we are now looking at almost 80 seats on the lawn. If you want to book yours please do so this weekend so I can sort out catering etc HERE. I start with economics lessons for the NHS and greedy and lazy Shipmans, then onto Cineworld (CINE), then thanks to Evil Banksta, what is an RCF and musicMagpie (MMAG). Finally today's new issue Zamaz (ZAMZ) a £77 million IPO worth, £350,000. This is a true shocker. What is the FCA thinking about in permitting this to list on the Standard List?

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 08:25:49